Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1166 | 1022 | 1227 | 1060 | 1633 | - |
Fund Return | 16.59% | 2.16% | 22.7% | 1.96% | 10.31% | - |
Place in category | 1136 | 1266 | 1212 | 1269 | 609 | - |
% in Category | 42 | 48 | 45 | 54 | 36 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Funde | 15.79B | 18.34 | 3.65 | 10.83 | ||
Capital Group New Perspective Funbe | 15.79B | 17.23 | 2.61 | 9.75 | ||
Capital Group New Perspective Funze | 15.79B | 18.04 | 3.39 | 10.62 | ||
Capital Group New Perspective Fuzde | 15.79B | 18.05 | 3.39 | 10.62 | ||
Cap Group New Perspective lux C EUR | 15.79B | 18.93 | 4.21 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fuzde | 15.79B | 18.05 | 3.39 | 10.62 | ||
LU2133218979 | 15.79B | 18.24 | 3.54 | - | ||
Capital Group New Perspective Fuzge | 15.79B | 18.06 | 3.40 | 10.63 | ||
Capital Group New Perspective Fube | 15.79B | 17.23 | 2.61 | 9.75 | ||
Capital Group New Perspective Fubde | 15.79B | 17.25 | 2.62 | 9.75 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 3.78 | 585.25 | -1.73% | |
Microsoft | US5949181045 | 3.26 | 436.60 | -0.10% | |
Taiwan Semicon | TW0002330008 | 3.23 | 1,035.00 | -3.27% | |
Broadcom | US11135F1012 | 2.79 | 220.79 | +1.13% | |
Novo Nordisk B | DK0062498333 | 2.50 | 589.2 | -20.72% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review